Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000897069-23-000695
Filing Date
2023-06-07
Accepted
2023-06-07 14:43:48
Documents
5
Group Members
FURNEAUX CAPITAL HOLDCO, LLCSERIES GREENLIGHT 2, A SEPARATE SERIES OF BLUEIO GROWTH LLCVELOCITY FINANCIAL GROUP, LLC

Document Format Files

Seq Description Document Type Size
1 greenlight13d.htm SC 13D 204819
2 planofmerger.htm EX-99.1 544270
3 convertiblenoteagreement.htm EX-99.2 368815
4 contribexchangeagreement.htm EX-99.3 623229
5 image0.jpg GRAPHIC 39788
  Complete submission text file 0000897069-23-000695.txt   1797774
Mailing Address C/O GOODWIN PARTNERS 200 SUMMIT DRIVE, 2ND FLOOR BURLINGTON MA 01803
Business Address C/O GOODWIN PARTNERS 200 SUMMIT DRIVE, 2ND FLOOR BURLINGTON MA 01803 (617) 899-0294
Series Greenlight, a separate series of BlueIO Growth LLC (Filed by) CIK: 0001761971 (see all company filings)

EIN.: 832781126 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Subject) CIK: 0001822691 (see all company filings)

EIN.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92011 | Film No.: 23998671
SIC: 2836 Biological Products, (No Diagnostic Substances)